| Rank |
Title |
Year |
PubWeight™‹?› |
|
1
|
Intravascular reduction of methemoglobin in plasma of the rat in vivo.
|
1992
|
0.85
|
|
2
|
Overview of progress in the fluorocarbon approach to in vivo oxygen delivery.
|
1992
|
0.84
|
|
3
|
PEG-bovine hemoglobin: safety in a canine dehydrated hypovolemic-hemorrhagic shock model.
|
1992
|
0.84
|
|
4
|
Response of the rabbit lung as a criterion of safety for fluorocarbon breathing and blood substitutes.
|
1992
|
0.83
|
|
5
|
Protective effects of a novel perfluorochemical emulsion in photodynamic therapy.
|
1992
|
0.82
|
|
6
|
A liposome based platelet substitute, the plateletsome, with hemostatic efficacy.
|
1993
|
0.82
|
|
7
|
Increased concentrations of free light chain lambda in sera from chronic hemodialysis patients.
|
1991
|
0.82
|
|
8
|
Enhanced attachment and growth of human endothelial cells derived from umbilical veins on ammonia plasma modified surfaces of PTFE and ePTFE synthetic vascular graft biomaterials.
|
1993
|
0.81
|
|
9
|
Fluosol and hyperbaric oxygen as an adjunct to radiation therapy in the treatment of malignant gliomas: a pilot study.
|
1992
|
0.81
|
|
10
|
Pharmacokinetic studies in the rat on a o-raffinose polymerized human hemoglobin.
|
1992
|
0.81
|
|
11
|
Particle size distribution of concentrated perfluorocarbon emulsions by sedimentation field flow fractionation.
|
1992
|
0.81
|
|
12
|
The use of semifluorinated alkanes in blood-substitutes.
|
1993
|
0.80
|
|
13
|
Biodistribution studies of liposome encapsulated hemoglobin (LEH) studied with a newly developed 99m-technetium liposome label.
|
1992
|
0.80
|
|
14
|
Effect of Oxygent (perflubron emulsion) on leukocyte-endothelial interaction in postcapillary venules.
|
1992
|
0.80
|
|
15
|
Simultaneous nitrification and denitrification using immobilized microorganisms.
|
1993
|
0.80
|
|
16
|
Physiological behaviour of encapsulated somatic embryos.
|
1993
|
0.80
|
|
17
|
Artificial blood and extracorporeal circulation (ECC).
|
1992
|
0.80
|
|
18
|
A potential blood substitute from carboxylic dextran and oxyhemoglobin. I. Preparation, purification and characterization.
|
1992
|
0.79
|
|
19
|
Bioencapsulation in biotechnology.
|
1993
|
0.79
|
|
20
|
Biocompatibility of alkyl and perfluoroalkyl telomeric surfactants derived from THAM.
|
1993
|
0.79
|
|
21
|
A novel two step procedure for immobilizing living cells in microcapsules for improving xenograft survival.
|
1991
|
0.79
|
|
22
|
Myasthenia gravis (MG) treatment with immunoadsorbent columns.
|
1991
|
0.79
|
|
23
|
Cross-linked hemoglobin-superoxide dismutase-catalase scavenges oxygen-derived free radicals and prevents methemoglobin formation and iron release.
|
1993
|
0.79
|
|
24
|
Pilot scale production of pyrogen-free human hemoglobin for research.
|
1992
|
0.79
|
|
25
|
Oxygen delivery from fluorocarbon emulsions--aspects of convective and diffusive transport.
|
1992
|
0.78
|
|
26
|
Preparation, properties and biological function of liposome encapsulated hemoglobin.
|
1992
|
0.78
|
|
27
|
Validation of virus inactivation by heat treatment in the manufacture of diaspirin crosslinked hemoglobin.
|
1992
|
0.78
|
|
28
|
Short-term effect of guided bone regeneration and electrical stimulation on bone growth in a surgically modelled resorbed dog mandibular ridge.
|
1992
|
0.78
|
|
29
|
Biodegradable chitosan matrix for the controlled release of steroids.
|
1991
|
0.78
|
|
30
|
Preclinical evaluation of Oxygent as an adjunct to radiotherapy.
|
1992
|
0.78
|
|
31
|
Free and microencapsulated Erwinia herbicola for the production of tyrosine.
|
1993
|
0.78
|
|
32
|
Blood substitutes based on modified hemoglobin prepared by encapsulation or crosslinking: an overview.
|
1992
|
0.78
|
|
33
|
Effects of intravenous infusions of diaspirin cross-linked hemoglobin (DCLHb) on sheep.
|
1992
|
0.78
|
|
34
|
A nonlinear analysis of pulsatile blood flow applied to investigate shear stress in arterial prostheses.
|
1992
|
0.77
|
|
35
|
Synthesis and properties of polymerized, diaspirin cross-linked hemoglobins.
|
1992
|
0.77
|
|
36
|
Dehydration and shock: an animal model of hemorrhage and resuscitation of battlefield injury.
|
1992
|
0.77
|
|
37
|
The microencapsulation of cells within alginate poly-L-lysine microcapsules prepared with the standard single step drop technique: histologically identified membrane imperfections and the associated graft rejection.
|
1991
|
0.77
|
|
38
|
Effect of a single replacement of one of Ringer lactate, hypertonic saline/dextran, 7g% albumin, stroma-free hemoglobin, o-raffinose polyhemoglobin or whole blood on the long term survival of unanesthetized rats with lethal hemorrhagic shock after 67% acute blood loss.
|
1992
|
0.77
|
|
39
|
Development of highly fluid, concentrated and stable fluorocarbon emulsions for diagnosis and therapy.
|
1992
|
0.77
|
|
40
|
Artificial cells in immobilization biotechnology.
|
1992
|
0.77
|
|
41
|
Leaching of plasticizers from and surface characterization of PVC blood platelet bags.
|
1991
|
0.77
|
|
42
|
Prolonged biochemical and morphological stability of encapsulated liver cells--a new method.
|
1993
|
0.77
|
|
43
|
Effects of liposome encapsulated hemoglobin on the reticuloendothelial system.
|
1992
|
0.77
|
|
44
|
Rheology of concentrated perfluorocarbon emulsions.
|
1992
|
0.77
|
|
45
|
Polydisperse dextran as a diffusing test solute to study the membrane permeability of alginate polylysine microcapsules.
|
1993
|
0.77
|
|
46
|
Blood substitutes made on the basis of perfluorocarbons inhibit intracellular energy generation.
|
1992
|
0.77
|
|
47
|
Elimination of pyridoxylated polyhemoglobin after partial exchange transfusion in chimpanzees.
|
1991
|
0.76
|
|
48
|
Genetically engineered E. coli cells containing K. aerogenes gene, microencapsulated in artificial cells for urea and ammonia removal.
|
1993
|
0.76
|
|
49
|
Expression and assembly of functional human hemoglobin in S. cerevisiae.
|
1992
|
0.76
|
|
50
|
Physicochemical characteristics of hepatic stimulatory factor prepared from cell free supernatant of hepatocyte cultures.
|
1991
|
0.76
|